Date Fruit Extract / Bcl-2 Cancer Research Results

DFE, Date Fruit Extract: Click to Expand ⟱
Features:
Dates (the fruit of Phoenix dactylifera) have been increasingly studied for their potential anticancer and cancer-preventive properties, mainly due to their rich phytochemical content and strong antioxidant activity.
Dates contain a broad spectrum of bioactive compounds linked to cancer prevention:
-Phenolic acids – e.g., ferulic acid, gallic acid, caffeic acid, and p-coumaric acid
-Flavonoids – e.g., quercetin, luteolin, apigenin
-Carotenoids – e.g., β-carotene, lutein
-Tannins, saponins, and sterols
-Dietary fiber and polysaccharides
These compounds have antioxidant, anti-inflammatory, and antiproliferative effects.

Date fiber and polyphenols foster beneficial gut bacteria (e.g., Bifidobacterium, Lactobacillus) that produce short-chain fatty acids (SCFAs), which protect the colon and may lower colon cancer risk.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Nrf2 / ARE antioxidant response Context-dependent modulation Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Polyphenol-driven antioxidant response is the dominant mechanistic theme in non-malignant systems.
2 ROS / oxidative stress modulation ROS ↓ (generally); pro-oxidant effects not dominant Oxidative stress ↓ P, R Antioxidant effect Most studies describe antioxidant protection rather than tumor-selective ROS elevation.
3 NF-κB inflammatory signaling NF-κB ↓ (reported in limited models) Inflammation tone ↓ R, G Anti-inflammatory modulation Observed in inflammatory and oxidative injury systems; tumor-specific evidence is limited.
4 Intrinsic apoptosis (mitochondrial; limited data) Apoptosis ↑ (reported in some in-vitro studies) ↔ G Conditional cytotoxicity Cytotoxic effects generally mild and concentration-dependent; not comparable to strong pro-oxidants.
5 Cell-cycle arrest Cell-cycle modulation ↑ (limited evidence) ↔ G Cytostasis (weak) Evidence exists but is inconsistent and often extract-dependent.
6 PI3K → AKT signaling Limited data; possible ↓ (reported in some systems) ↔ R, G Survival pathway modulation Not a consistently demonstrated primary mechanism.
7 Angiogenesis signaling (VEGF) Limited data; possible ↓ ↔ G Potential anti-angiogenic effect Evidence sparse compared to stronger polyphenols like gallic or caffeic acid.
8 Invasion / metastasis (MMPs) Limited evidence ↔ G Uncertain tumor relevance Not well characterized mechanistically in oncology models.
9 Metabolic modulation Indirect via anti-inflammatory and antioxidant tone Metabolic support ↑ R, G Systemic metabolic effect Better supported in cardiometabolic contexts than direct anticancer contexts.
10 Extract variability / compositional heterogeneity Activity varies by cultivar, processing, solvent — — Translation constraint Whole fruit extracts differ significantly in phenolic profile and potency.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid antioxidant interactions)
  • R: 30 min–3 hr (acute transcriptional shifts)
  • G: >3 hr (gene-regulatory and phenotype-level outcomes)
Bcl-2, B-cell CLL/lymphoma 2: Click to Expand ⟱
Source: HalifaxProj (inhibit) CGL-Driver Genes
Type: Antiapoptotic Oncogene
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL, the pro-apoptotic proteins represented by BAX and Bak, and the pro-apoptotic BH3-only proteins represented by BAD and BID.
Since the expression of Bcl-2 protein in tumor cells is much higher than that in normal cells, inhibitors targeting it have little effect on normal cells.
Scientific Papers found: Click to Expand⟱
4455- DFE,    Ajwa Date (Phoenix dactylifera L.) Extract Inhibits Human Breast Adenocarcinoma (MCF7) Cells In Vitro by Inducing Apoptosis and Cell Cycle Arrest
- in-vitro, BC, MCF-7 - in-vitro, Nor, 3T3
TumCCA↑, P53↑, BAX↑, Casp3↑, MMP↓, Fas↑, FasL↑, Bcl-2↓, Apoptosis↑, TumCP↓, TUNEL↑, eff↑, selectivity↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Cell Death ⓘ

Apoptosis↑, 1,   BAX↑, 1,   Bcl-2↓, 1,   Casp3↑, 1,   Fas↑, 1,   FasL↑, 1,   TUNEL↑, 1,  

DNA Damage & Repair ⓘ

P53↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Migration ⓘ

TumCP↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,   selectivity↑, 1,  
Total Targets: 13

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Bcl-2, B-cell CLL/lymphoma 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:371  Target#:27  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page